Form 4: Finch Therapeutics Director Jeffery Smisek Sells Shares
SEC Form 4 Filing
Director Jeffery Smisek reports selling shares of Finch Therapeutics Group, Inc. on March 28, 2024.
Summary
- On March 28, 2024, Jeffery A. Smisek, a director of Finch Therapeutics Group, Inc., sold 6,642 shares of common stock at a weighted average price of $2.57.
- Smisek's spouse also sold 1,600 shares at a weighted average price of $2.61 on the same day.
- Following these transactions, Smisek directly owns no shares and indirectly owns 46,772 shares.
- 40,260 of the indirectly owned shares are held by Flight Partners Management LLC, where Smisek is the president.
Sentiment
Score: 5
Explanation: The document is a neutral report of stock sales by a company director and his spouse, with no inherent positive or negative implications.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, which is common in the biotechnology industry.
Stakeholder Impact
- The sale of shares by a director could be perceived negatively by some shareholders, potentially leading to a slight decrease in investor confidence.
Key Dates
| Date | Description |
|---|---|
| 03/28/2024 | Date of transaction: Jeffery Smisek sold 6,642 shares and his spouse sold 1,600 shares. |
| 03/29/2024 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Finch Therapeutics, Share Sale, Director, Smisek, FNCH
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.